26 January 2022 (Wednesday) - Transfusion News Update

The nice people at “Transfusion News” sent their update today. I was a tad vague on what the first article was about, but the article on the use of convalescent plasma was intriguing, if only because opinion seems to be utterly divided on the matter right now…

RBCeq: A Novel, User-Friendly, Algorithm for Genetic Blood Typing

January 26, 2022 About 85 million units of red blood cells (RBCs) are transfused globally, and some patients requiring multiple transfusions are at a high risk of alloimmunization. Currently, serology is the gold standard for RBC phenotyping and matching. Recently, molecular methods utilizing DNA microarrays and single nucleotide polymorphism (SNP) genotyping have enabled large-scale typing, but these methods are incapable of identifying novel blood groups. [Read More]


Covid 19 Convalescent Plasma in the Omicron Era

Join Transfusion News Associate Editors Daniela Hermelin MD and Monica Pagano MD on Twitter Space this Friday January 28 from 11:00-11:30 AM EST for the first ever #Blooducation Baristas live event. Dr. Hermelin and Dr. Pagano will be serving up piping hot Transfusion News along with Evan Bloch MD, Claudia Cohn MD, and BJ Grossman MD. [Set a reminder to join us]


Variable Transfusion Practices for Bleeding ICU Patients Globally

January 19, 2022 Approximately 40-50% of patients in the intensive care unit (ICU) receive blood transfusions. Many studies have focused on bleeding in trauma patients who are usually healthy. Patients in the ICU, however, more often have multiple comorbidities and may require a more nuanced transfusion approach. [Read More]


Plasma Exchange for Hypertriglyceridemic Acute Pancreatitis

January 11, 2022 Acute pancreatitis can be caused by many etiologies including high levels of plasma triglycerides. Hypertriglyceridemic acute pancreatitis (HTGAP) can cause life-threatening complications such as multi-organ failure. While plasma exchange is used to quickly lower plasma triglyceride concentrations, the benefits of this treatment are not clear. [Read More]


No comments:

Post a Comment